Stock Earnings
Potential Price Increase for Banc of California Inc (BANC) After Recent Insider Activity
Banc of California Inc’s filing revealed that its Director WARBURG PINCUS LLC unloaded Company’s shares for reported $73.71 million on ...
Analyzing Lexaria Bioscience Corp (LEXX) After Recent Trading Activity
Lexaria Bioscience Corp’s filing revealed that its Director BUNKA CHRISTOPHER acquired Company’s shares for reported $14375.0 on Jul 29 ’25. ...
The Potential Rise in the Price of Destiny Tech100 Inc (DXYZ) following insiders activity
Destiny Tech100 Inc’s filing revealed that its President and CEO Prasad Sohail unloaded Company’s shares for reported $12.97 million on ...
Sensata Technologies Holding Plc [ST] Investment Appeal on the Rise
Sensata Technologies Holding Plc’s filing revealed that its Director Mirshekari Ali John unloaded Company’s shares for reported $3.63 million on ...
Taking a Closer Look At Blink Charging Co (BLNK) Following Its Recent Trade
Blink Charging Co’s filing revealed that its Chief Financial Officer Bercovich Michael acquired Company’s shares for reported $50392.0 on Dec ...
Investing in Thermo Fisher Scientific Inc (TMO) Is Getting More Attractive
Thermo Fisher Scientific Inc’s filing revealed that its Executive Vice President & COO Lagarde Michel unloaded Company’s shares for reported ...
Fabrinet’s latest rating changes from various analysts
Fabrinet’s filing revealed that its Director Knight Darlene S. unloaded Company’s shares for reported $0.24 million on Dec 05 ’25. ...
Morgan Stanley upgrades Vertex Pharmaceuticals, Inc (VRTX) rating to an Overweight
Vertex Pharmaceuticals, Inc’s filing revealed that its EVP, CO & FO WAGNER CHARLES F JR unloaded Company’s shares for reported ...
Deutsche Bank gives a Buy recommendation for Shift4 Payments Inc (FOUR)
Shift4 Payments Inc’s filing revealed that its Director Disman Nancy acquired Company’s shares for reported $0.35 million on Dec 11 ...
Recent Insider Activity Suggests Potential Gains for Fulcrum Therapeutics Inc (FULC)
Fulcrum Therapeutics Inc’s filing revealed that its 10% Owner RA CAPITAL MANAGEMENT, L.P. unloaded Company’s shares for reported $58.38 million ...
